{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:56:17Z","timestamp":1790085377761,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Although exogenous ketogenic dietary supplements continue to grow in popularity, their pharmacokinetic properties have not been adequately studied, thus hindering their optimal use and benefits. Here, the metabolic characteristics of one such supplement (Veech ketone mono-ester ((<jats:italic>R<\/jats:italic>)-3-hydroxybutyl(<jats:italic>R<\/jats:italic>)-3-hydroxybutyrate) (KE)) were studied along with its metabolite- (R)-1,3-butanediol ((R)-1,3-BD), both of which are precursors and undergo metabolic conversion to (R)-beta-hydroxybutyrate (BHB). The metabolism of aldol (an aldehyde intermediate between the conversion of (R)-1,3-BD to (R)-BHB was also evaluated, as it is frequently not considered in any scientific discussion. The metabolic parameters were calculated using pooled human (mixed gender) and pooled rat (male and female) liver fractions. These were later used to estimate the hepatic extraction ratio and the hepatic clearance of these molecules. KE showed rapid and non-saturable clearance in human and rat liver fractions, even at concentrations as high as 15,000\u00a0\u03bcM. In the case of (R)-1,3-BD, there was saturable metabolism in rats and humans with K<jats:sub>m<\/jats:sub> and V<jats:sub>max<\/jats:sub> values of 8,000\u00a0\u03bcM and 27.1\u00a0nmol\/min\/mg of protein (humans), 19,300\u00a0\u03bcM and 113.5\u00a0nmol\/min\/mg of protein (male rats), and 11,910\u00a0\u03bcM and 75.8\u00a0nmol\/min\/mg of protein (female rats). The metabolism of aldol showed rapid and non-saturable hepatic clearance in human\u00a0liver fractions.<\/jats:p>","DOI":"10.1208\/s12248-025-01044-7","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T17:11:38Z","timestamp":1741972298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Characterizing the Hepatic Metabolic Pathway of Ketone Ester and Subsequent Metabolites Using Human and Rat Liver Fractions"],"prefix":"10.1208","volume":"27","author":[{"given":"N.","family":"Panse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9861-1018","authenticated-orcid":false,"given":"P. M.","family":"Gerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"1611","key":"1044_CR1","doi-asserted-by":"publisher","first-page":"740374","DOI":"10.3389\/fmed.2021.740374","volume":"8","author":"H White","year":"2021","unstructured":"White H, Heffernan AJ, Worrall S, Grunsfeld A, Thomas M. A Systematic Review of Intravenous \u03b2-Hydroxybutyrate Use in Humans \u2013 A Promising Future Therapy? Front Med. 2021;8(1611):740374.","journal-title":"Front Med."},{"issue":"3","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2016.08.021","volume":"24","author":"B Egan","year":"2016","unstructured":"Egan B, D\u2019Agostino DP. Fueling Performance: Ketones Enter the Mix. Cell Metab. 2016;24(3):373\u20135.","journal-title":"Cell Metab"},{"issue":"9","key":"1044_CR3","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1194\/jlr.R046599","volume":"55","author":"SA Hashim","year":"2014","unstructured":"Hashim SA, Vanitallie TB. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res. 2014;55(9):1818\u201326.","journal-title":"J Lipid Res"},{"issue":"2","key":"1044_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 2017;25(2):262\u201384.","journal-title":"Cell Metab"},{"issue":"8","key":"1044_CR5","first-page":"e9639-e","volume":"12","author":"JT Batch","year":"2020","unstructured":"Batch JT, Lamsal SP, Adkins M, Sultan S, Ramirez MN. Advantages and disadvantages of the ketogenic diet: a review article. Cureus. 2020;12(8):e9639-e.","journal-title":"Cureus."},{"key":"1044_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cophys.2019.04.010","volume":"10","author":"DJ Dearlove","year":"2019","unstructured":"Dearlove DJ, Faull OK, Clarke K. Context is key: exogenous ketosis and athletic performance. Curr Opin Physio. 2019;10:81\u20139.","journal-title":"Curr Opin Physio"},{"issue":"2","key":"1044_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.55460\/PGWG-H55J","volume":"17","author":"JM Scott","year":"2017","unstructured":"Scott JM, Deuster PA. Ketones and Human Performance. J Spec Oper Med. 2017;17(2):112\u20136.","journal-title":"J Spec Oper Med"},{"issue":"2","key":"1044_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","volume":"24","author":"PJ Cox","year":"2016","unstructured":"Cox PJ, Kirk T, Ashmore T, Willerton K, Evans R, Smith A, et al. Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes. Cell Metab. 2016;24(2):256\u201368.","journal-title":"Cell Metab."},{"issue":"848","key":"1044_CR9","first-page":"300397","volume":"8","author":"BJ Stubbs","year":"2017","unstructured":"Stubbs BJ, Cox PJ, Evans RD, Santer P, Miller JJ, Faull OK, et al. On the Metabolism of Exogenous Ketones in Humans. Front Physiol. 2017;8(848):300397.","journal-title":"Front Physiol."},{"issue":"2","key":"1044_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/advances\/nmz104","volume":"11","author":"LM Margolis","year":"2019","unstructured":"Margolis LM, O\u2019Fallon KS. Utility of Ketone Supplementation to Enhance Physical Performance: A Systematic Review. Adv Nutr. 2019;11(2):412\u20139.","journal-title":"Adv Nutr"},{"issue":"10","key":"1044_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1139\/apnm-2016-0641","volume":"42","author":"T O'Malley","year":"2017","unstructured":"O\u2019Malley T, Myette-Cote E, Durrer C, Little JP. Nutritional ketone salts increase fat oxidation but impair high-intensity exercise performance in healthy adult males. Appl Physiol Nutr Metab. 2017;42(10):1031\u20135.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"8","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, et al. The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation. 2016;133(8):698\u2013705.","journal-title":"Circulation"},{"issue":"16","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"681513","DOI":"10.3389\/fragi.2021.681513","volume":"2","author":"Y Chu","year":"2021","unstructured":"Chu Y, Zhang C, Xie M. Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts. Front Aging. 2021;2(16):681513.","journal-title":"Front Aging."},{"issue":"11","key":"1044_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","volume":"26","author":"QG Karwi","year":"2020","unstructured":"Karwi QG, Biswas D, Pulinilkunnil T, Lopaschuk GD. Myocardial Ketones Metabolism in Heart Failure. J Cardiac Fail. 2020;26(11):998\u20131005.","journal-title":"J Cardiac Fail"},{"issue":"22","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","volume":"141","author":"S Selvaraj","year":"2020","unstructured":"Selvaraj S, Kelly DP, Margulies KB. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure. Circulation. 2020;141(22):1800\u201312.","journal-title":"Circulation"},{"issue":"6","key":"1044_CR16","first-page":"e006573","volume":"13","author":"NJ Byrne","year":"2020","unstructured":"Byrne NJ, Soni S, Takahara S, Ferdaoussi M, Al Batran R, Darwesh AM, et al. Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure. Circ: Heart Fail. 2020;13(6):e006573.","journal-title":"Circ: Heart Fail."},{"issue":"6","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1080\/1028415X.2020.1853414","volume":"25","author":"C Almeida-Suhett","year":"2022","unstructured":"Almeida-Suhett C, Namboodiri AM, Clarke K, Deuster PA. The ketone ester, 3-hydroxybutyl-3-hydroxybutyrate, attenuates neurobehavioral deficits and improves neuropathology following controlled cortical impact in male rats. Nutr Neurosci. 2022;25(6):1287\u201399.","journal-title":"Nutr Neurosci"},{"issue":"2","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/cc10020","volume":"15","author":"H White","year":"2011","unstructured":"White H, Venkatesh B. Clinical review: Ketones and brain injury. Crit Care. 2011;15(2):219.","journal-title":"Crit Care"},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"111859","DOI":"10.1016\/j.fct.2020.111859","volume":"147","author":"BJ Stubbs","year":"2021","unstructured":"Stubbs BJ, Blade T, Mills S, Thomas J, Yufei X, Nelson FR, et al. In vitro stability and in vivo pharmacokinetics of the novel ketogenic ester, bis hexanoyl (R)-1,3-butanediol. Food Chem Toxicol. 2021;147:111859.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"1044_CR20","doi-asserted-by":"publisher","first-page":"10591","DOI":"10.1038\/s41598-022-14961-w","volume":"12","author":"R Weckx","year":"2022","unstructured":"Weckx R, Goossens C, Derde S, Pauwels L, Vander Perre S, Van Den Berghe G, et al. Efficacy and safety of ketone ester infusion to prevent muscle weakness in a mouse model of sepsis-induced critical illness. Sci Rep. 2022;12(1):10591.","journal-title":"Sci Rep."},{"issue":"1","key":"1044_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1042\/BST20190240","volume":"48","author":"A Soto-Mota","year":"2020","unstructured":"Soto-Mota A, Norwitz NG, Clarke K. Why a d-\u03b2-hydroxybutyrate monoester? Biochem Soc Trans. 2020;48(1):51\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"1044_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/ijms22020524","volume":"22","author":"L Suissa","year":"2021","unstructured":"Suissa L, Kotchetkov P, Guigonis J-M, Doche E, Osman O, Pourcher T, et al. Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice. Int J Mol Sci. 2021;22(2):524.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1208\/s12248-016-9879-0","volume":"18","author":"V Shivva","year":"2016","unstructured":"Shivva V, Cox PJ, Clarke K, Veech RL, Tucker IG, Duffull SB. The Population Pharmacokinetics of d-\u03b2-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate. AAPS J. 2016;18(3):678\u201388.","journal-title":"AAPS J"},{"issue":"2","key":"1044_CR24","first-page":"169","volume":"42","author":"CD Crabtree","year":"2022","unstructured":"Crabtree CD, Blade T, Hyde PN, Buga A, Kackley ML, Sapper TN, et al. Bis Hexanoyl (R)-1,3-Butanediol, a Novel Ketogenic Ester, Acutely Increases Circulating r- and s-\u00df-Hydroxybutyrate Concentrations in Healthy Adults. J Am Nutr Assoc. 2022;42(2):169\u201377.","journal-title":"J Am Nutr Assoc."},{"issue":"2","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.yrtph.2012.04.001","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R, Carter E, Knight NS, Murray AJ, et al. Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. Regul Toxicol Pharmacol. 2012;63(2):196\u2013208.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R, Carter E, Todd King M, Musa-Veloso K, et al. Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol. 2012;63(3):401\u20138.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"2","key":"1044_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1527-3458.2005.tb00265.x","volume":"11","author":"SL Smith","year":"2006","unstructured":"Smith SL, Heal DJ, Martin KF. KTX 0101: A Potential Metabolic Approach to Cytoprotection in Major Surgery and Neurological Disorders. CNS Drug Rev. 2006;11(2):113\u201340.","journal-title":"CNS Drug Rev"},{"issue":"7","key":"1044_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1208\/s12249-023-02633-5","volume":"24","author":"N Panse","year":"2023","unstructured":"Panse N, Halquist M, Gerk PM. Quantitative Determination of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate (Ketone Ester) and Its Metabolites Beta-hydroxybutyrate, 1-3-Butanediol, and Acetoacetate in Human Plasma Using LC-MS. AAPS PharmSciTech. 2023;24(7):184.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1044_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/03602532.2018.1555587","volume":"51","author":"A Ahmed Laskar","year":"2019","unstructured":"Ahmed Laskar A, Younus H. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Drug Metab Rev. 2019;51(1):42\u201364.","journal-title":"Drug Metab Rev"},{"key":"1044_CR30","doi-asserted-by":"publisher","first-page":"962718","DOI":"10.3389\/fphar.2022.962718","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Liu Y, Zhou X, Xu Z, Zhang Y, Ji L, et al. Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap. Front Pharmacol. 2022;13:962718.","journal-title":"Front Pharmacol."},{"key":"1044_CR31","unstructured":"Pearson PG, Wienkers LC (eds). Handbook of drug metabolism. 2nd ed. New York: Informa Healthcare USA; 2009."},{"issue":"6","key":"1044_CR32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00210-011-0627-9","volume":"383","author":"D Lenz","year":"2011","unstructured":"Lenz D, J\u00fcbner M, Bender K, Wintermeyer A, Beike J, Rothschild MA, et al. Inhibition of 1,4-butanediol metabolism in human liver in vitro. Naunyn Schmiedebergs Arch Pharmacol. 2011;383(6):647\u201354.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"11","key":"1044_CR33","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1124\/dmd.117.077040","volume":"45","author":"FL Wood","year":"2017","unstructured":"Wood FL, Houston JB, Hallifax D. Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes\/Microsomes and Implications for Experimental Methodology. Drug Metab Dispos. 2017;45(11):1178\u201388.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"1044_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1124\/dmd.105.007658","volume":"34","author":"D Hallifax","year":"2006","unstructured":"Hallifax D, Houston JB. Binding Of Drugs To Hepatic Microsomes: Comment And Assessment Of Current Prediction Methodology With Recommendation For Improvement: Fig. 1. Drug Metab Dispos. 2006;34(4):724\u20136.","journal-title":"Drug Metab Dispos."},{"issue":"5","key":"1044_CR35","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1124\/dmd.31.5.580","volume":"31","author":"Y Naritomi","year":"2003","unstructured":"Naritomi Y, Terashita S, Kagayama A, Sugiyama Y. Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in vivo and in vitro. Drug Metab Dispos. 2003;31(5):580\u20138.","journal-title":"Drug Metab Dispos"},{"key":"1044_CR36","unstructured":"Obied TYR. In-vitro metabolism and protein binding of 5-HMF, a potential antisickling agent. [Master of Science thesis, Virginia Commonwealth University]. OCLC: (OCoLC)657134542. 2006."},{"key":"1044_CR37","unstructured":"Gupta P. Interspecies pharmacokinetic scaling and metabolism of alcohols and glycols.\u00a0[Doctoral dissertation, Virginia Commonwealth University]. OCLC: (OCoLC)70963796. 2006."},{"issue":"3","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0009-2797(01)00276-9","volume":"138","author":"JJP Bogaards","year":"2001","unstructured":"Bogaards JJP, Freidig AP, van Bladeren PJ. Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling. Chem Biol Interact. 2001;138(3):247\u201365.","journal-title":"Chem Biol Interact"},{"issue":"7","key":"1044_CR39","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/0006-2952(93)90459-A","volume":"46","author":"NW McCracken","year":"1993","unstructured":"McCracken NW, Blain PG, Williams FM. Human xenobiotic metabolizing esterases in liver and blood. Biochem Pharmacol. 1993;46(7):1125\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1044_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/187231209788654081","volume":"3","author":"ML Berry","year":"2009","unstructured":"Berry ML, Wollenberg L, Zhao Z. Esterase Activities in the Blood, Liver and Intestine of Several Preclinical Species and Humans. Drug Metab Lett. 2009;3(2):70\u20137.","journal-title":"Drug Metab Lett"},{"issue":"1","key":"1044_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0090-9556(25)07241-1","volume":"24","author":"LE Los","year":"1996","unstructured":"Los LE, Welsh DA, Herold EG, Bagdon WJ, Zacchei AG. Gender differences in toxicokinetics, liver metabolism, and plasma esterase activity: observations from a chronic (27-week) toxicity study of enalapril\/diltiazem combinations in rats. Drug Metab Dispos. 1996;24(1):28\u201333.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1044_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/phar.1194","volume":"33","author":"S Casey Laizure","year":"2013","unstructured":"Casey Laizure S, Herring V, Hu Z, Witbrodt K, Parker RB. The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? Pharmacotherapy: J Human Pharmacol Drug Ther. 2013;33(2):210\u201322.","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Ther."},{"issue":"6","key":"1044_CR43","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/jps.20542","volume":"95","author":"BM Liederer","year":"2006","unstructured":"Liederer BM, Borchardt RT. Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci. 2006;95(6):1177\u201395.","journal-title":"J Pharm Sci"},{"key":"1044_CR44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bioorg.2018.09.018","volume":"81","author":"KM Huttunen","year":"2018","unstructured":"Huttunen KM. Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen. Bioorg Chem. 2018;81:494\u2013503.","journal-title":"Bioorg Chem"},{"issue":"3","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0024-3205(90)90108-4","volume":"46","author":"A Zorzano","year":"1990","unstructured":"Zorzano A, Herrera E. In vivo ethanol elimination in man, monkey and rat: A lack of relationship between the ethanol metabolism and the hepatic activities of alcohol and aldehyde dyhydrogenases. Life Sci. 1990;46(3):223\u201330.","journal-title":"Life Sci"},{"key":"1044_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cbi.2014.12.040","volume":"234","author":"BV Plapp","year":"2015","unstructured":"Plapp BV, Leidal KG, Murch BP, Green DW. Contribution of liver alcohol dehydrogenase to metabolism of alcohols in rats. Chem Biol Interact. 2015;234:85\u201395.","journal-title":"Chem Biol Interact"},{"key":"1044_CR47","doi-asserted-by":"publisher","first-page":"1196535","DOI":"10.3389\/fphys.2023.1196535","volume":"14","author":"E Mah","year":"2023","unstructured":"Mah E, Blonquist TM, Kaden VN, Beckman D, Boileau AC, Anthony JC, et al. A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestion in healthy adults. Front Physiol. 2023;14:1196535.","journal-title":"Front Physiol."},{"issue":"5","key":"1044_CR48","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1123\/ijsnem.2018-0284","volume":"29","author":"DM Shaw","year":"2019","unstructured":"Shaw DM, Merien F, Braakhuis A, Plews D, Laursen P, Dulson DK. The Effect of 1,3-Butanediol on Cycling Time-Trial Performance. Int J Sport Nutr Exerc Metab. 2019;29(5):466\u201373.","journal-title":"Int J Sport Nutr Exerc Metab"},{"issue":"3","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1124\/jpet.121.000796","volume":"379","author":"CG McCarthy","year":"2021","unstructured":"McCarthy CG, Waigi EW, Singh G, Castaneda TR, Mell B, Chakraborty S, et al. Physiologic, metabolic, and toxicologic profile of 1,3-butanediol. J Pharmacol Exp Therap. 2021;379(3):245\u201352.","journal-title":"J Pharmacol Exp Therap."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01044-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01044-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01044-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T03:25:34Z","timestamp":1743045934000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01044-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":49,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01044-7","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"65"}}